- Valuation
- ₹17,880 Cr

About Transasia Bio-Medicals Limited
Data last updated:
Transasia Bio-Medicals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 10 May 1985 and has been in existence for over 41 years.
Its director Suresh H Vazirani and family are #416 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33110MH1985PLC036198. Its GSTIN is 27AAACT2038C1ZT (Maharashtra). The company holds 18 GST registrations, of which 12 are active.
The company has an authorised share capital of ₹4.4 Cr and a paid-up capital of ₹4 Cr. It is led by directors including Sunil Hassanand Vazirani (Whole-Time Director) and Suresh Hassanand Vazirani.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Transasia House 8 Chandivali Studio Road, Mumbai, Maharashtra, India – 400072.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,097.22 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹202.19 Cr (net margin 18.4%) and EBITDA of ₹290.8 Cr (EBITDA margin 26.5%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 5% over five years.
The company has about 1,323 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries and 1 joint venture.
The company is associated with 2 brands: Care Data Infomatics and Transasia Bio-Medicals. As per MCA filings, the company has open charges of ₹108 Cr and satisfied charges of ₹999.7 Cr on record. Court records list 15,950 cases involving the company, including 15,815 filed by the company and 136 filed against it; 4,840 cases are pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2008. The company has 12 MSME Form 1 returns on record between 2018 and 2024, listing 194 overdue payments to 60 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website transasia.co.in.
Company details
CIN history
Transasia Bio-Medicals has one previous CIN (Corporate Identification Number): L33110MH1985PLC036198. The current CIN is U33110MH1985PLC036198, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33110MH1985PLC036198 | Current |
| L33110MH1985PLC036198 | Previous |
Recognitions & Rankings of Transasia Bio-Medicals
- #416 Suresh H Vazirani & family ₹8,900 Cr
Contact details
Transasia Bio-Medicals Limited's registered office is in Mumbai, Maharashtra. Its website is transasia.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressTransasia House 8 Chandivali Studio Road, Mumbai, Maharashtra, India – 400072
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Transasia Bio-Medicals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Transasia Bio-Medicals operates two associated brands: Care Data Infomatics and Transasia Bio-Medicals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides cloud-based LIMS software for lab automation, data management, and efficiency improvements. | caredatainfo.com | |
| Diagnostic company specializing in the manufacture of in-vitro diagnostic instruments and solutions | transasia.co.in |
Business activity
The main business activities of Transasia Bio-Medicals are manufacturing, trade and support service to organizations. 4 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | |
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | |
| G | Trade | G2 | Retail Trading | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Transasia Bio-Medicals Limited, buy the company report.
Financials of Transasia Bio-Medicals Limited
FY 2025 filings availableTransasia Bio-Medicals Limited reported revenue of ₹1,097.22 Cr (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1,097.22 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹290.8 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹202.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.5% | ||||
| Net Profit Margin | 18.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Transasia Bio-Medicals Limited, buy the company report.
Board of directors of Transasia Bio-Medicals Limited
Transasia Bio-Medicals has 9 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
Auditor
Transasia Bio-Medicals Limited is audited by Walker Chandiok & Company LLP for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Walker Chandiok & Company LLP | FY 2025 | 001076N/N500013 |
Shareholding
The shareholding of Transasia Bio-Medicals Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Transasia Bio-Medicals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jul 2018 | 100193762 | The Hongkong and Shanghai Banking Corporation Limited | ₹20 Cr | Open | |
| 21 May 2014 | 10496177 | Citi Bank N.A. | ₹30 Cr | Open | |
| 07 Sep 2007 | 10072790 | Hdfc Bank Limited | ₹42 Cr | Open | |
| 30 Apr 2007 | 10051810 | The Royal Bank of Scotland N V | ₹16 Cr | Open | |
| 12 Jun 2019 | 100269038 | The Hongkong and Shanghai Banking Corporation Limited | ₹109.84 Cr | Satisfied |
To see the full charge records of Transasia Bio-Medicals Limited, buy the company report.
Total charge records: 25 View all charges
Deals & funding
Transasia Bio-Medicals Limited has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2008.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2008 | Funding round | ₹2 Cr | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Transasia Bio-Medicals Limited has 15,950 court cases on record: 15,815 filed by Transasia Bio-Medicals, 136 filed against it. 4,840 cases are pending and 11,110 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 15,713 | 72 | 4,801 |
| High courts | 216 | 47 | 38 |
| Supreme Court | 16 | 14 | 1 |
| NCLT | 5 | 3 | 0 |
Cases on record (5 of 15,950)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Criminal miscellaneous application | Filed by the company against Herbalayas Diabetes Care Foundation India Pvt.Ltd., and 1 other | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Cri.Appeal) | Filed by the company against M/S. Rexyn Pharmaceuticals Pvt Ltd. and 3 others | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against Zoetis Health OPC Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Criminal miscellaneous application | Filed by the company against Yashodhan Healthcare Pvt.Ltd.,Nashik and 1 other | Pending |
| High Court, MAHARASHTRA | Writ petition | Filed against the company by Dr Khannas Pathcare Pvt Ltd and Ors and 2 others | Pending |
To see the full case history of Transasia Bio-Medicals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Transasia Bio-Medicals Limited was last rated by Icra on 17 Jun 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 17 Jun 2021 |
To see the full credit ratings and regulatory alerts of Transasia Bio-Medicals Limited, buy the company report.
MSME payment delays
Transasia Bio-Medicals Limited has 12 MSME Form 1 returns on record between 2018 and 2024, listing 194 overdue payments to 60 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 60)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pentagon Packaging LLP | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Transasia Bio-Medicals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Transasia Bio-Medicals has 2 subsidiary companies and 1 joint venture. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Transasia Diagnostics Private Ltd | U24299MH2020PTC344692 | |
| Care Data Infomatics Private Limited | U72900TN2016PTC110158 |
To see the full group structure of Transasia Bio-Medicals Limited, buy the company report.
Employees & EPFO
Transasia Bio-Medicals Limited has a workforce of 1,323 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 1,323 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Transasia Bio-Medicals Limited, buy the company report.
GST
Transasia Bio-Medicals has 18 GST registrations: 12 active and 6 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACT2038C1ZT | Maharashtra | Active | 01 Jul 2017 |
| 27AAACT2038C3ZR | Maharashtra | Active | 19 Dec 2019 |
| 02AAACT2038C1Z5 | Himachal Pradesh | Active | 01 Jul 2017 |
| 08AAACT2038C1ZT | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Transasia Bio-Medicals Limited, buy the company report.
Recent activity
Transasia Bio-Medicals Limited has 22 board changes on record since 2008: 11 appointments and 11 cessations. The latest: Shiraz Bugwadia Homi was appointed as Director on 29 Sep 2025.
71 earlier events are in the company report.
News
Frequently asked questions
Transasia Bio-Medicals is an active public limited company based in Mumbai, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 10 May 1985 (41+ years old) and is registered under CIN U33110MH1985PLC036198.
Transasia Bio-Medicals has 9 current directors:
- Sunil Hassanand Vazirani - Whole-Time Director
- Suresh Hassanand Vazirani - Director
- Mala Suresh Vazirani - Director
- Rajendra Vadilal Gandhi - Additional Director
- Sanjay Surinder Arora - Director
- Vibhuti Suresh Vazirani - Director
- Shiraz Bugwadia Homi - Director
- Nishant Saxena - Director
- Nikhil Kumar Suresh Vazirani - Director
The latest financial statements of Transasia Bio-Medicals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Transasia Bio-Medicals is 27AAACT2038C1ZT, registered in Maharashtra. The company has 18 GST registrations in all, of which 12 are active and 6 are cancelled or inactive. Other active GSTINs include 27AAACT2038C3ZR (Maharashtra), 02AAACT2038C1Z5 (Himachal Pradesh), 08AAACT2038C1ZT (Rajasthan).
The CIN (Corporate Identification Number) of Transasia Bio-Medicals is U33110MH1985PLC036198. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Transasia Bio-Medicals has 15,950 court cases on record: 15,815 filed by the company and 136 filed against it. 4,840 are pending. Most are in the district courts.
Transasia Bio-Medicals was incorporated on 10 May 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.
Transasia Bio-Medicals has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2008.
Shiraz Bugwadia Homi was appointed as Director on 29 Sep 2025. Rajendra Vadilal Gandhi was appointed as Additional Director on 18 Jun 2025. Aditi Pradeep Pai was appointed as CFO on 01 Apr 2025. Transasia Bio-Medicals has 22 board changes on record in total.
Transasia Bio-Medicals has 12 MSME Form 1 returns on record between 2018 and 2024, listing 194 overdue payments to 60 micro and small suppliers. The latest return was filed on 25 Apr 2024.
Transasia Bio-Medicals can be reached through the website transasia.co.in. Its registered office is in Mumbai, Maharashtra, India.

